$11.27
4.16% yesterday
Nasdaq, Apr 28, 10:00 pm CET
ISIN
US2681582019
Symbol
DVAX

Dynavax Technologies Corporation Stock price

$11.27
-2.41 17.62% 1M
-0.12 1.05% 6M
-1.50 11.75% YTD
-0.07 0.62% 1Y
+2.06 22.37% 3Y
+7.42 192.73% 5Y
-10.25 47.63% 10Y
Nasdaq, Closing price Mon, Apr 28 2025
+0.45 4.16%
ISIN
US2681582019
Symbol
DVAX
Sector
Industry

Key metrics

Market capitalization $1.38b
Enterprise Value $920.17m
P/E (TTM) P/E ratio 64.51
EV/FCF (TTM) EV/FCF 15.30
EV/Sales (TTM) EV/Sales 3.32
P/S ratio (TTM) P/S ratio 4.98
P/B ratio (TTM) P/B ratio 2.37
Revenue growth (TTM) Revenue growth 19.36%
Revenue (TTM) Revenue $277.25m
EBIT (operating result TTM) EBIT $-2.07m
Free Cash Flow (TTM) Free Cash Flow $60.16m
Cash position $713.83m
EPS (TTM) EPS $0.17
P/E forward 32.73
P/S forward 4.22
EV/Sales forward 2.82
Short interest 21.52%
Show more

Is Dynavax Technologies Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Dynavax Technologies Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a Dynavax Technologies Corporation forecast:

4x Buy
80%
1x Sell
20%

Analyst Opinions

5 Analysts have issued a Dynavax Technologies Corporation forecast:

Buy
80%
Sell
20%

Financial data from Dynavax Technologies Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
277 277
19% 19%
100%
- Direct Costs 49 49
1% 1%
18%
228 228
25% 25%
82%
- Selling and Administrative Expenses 160 160
4% 4%
58%
- Research and Development Expense 62 62
12% 12%
22%
5.98 5.98
122% 122%
2%
- Depreciation and Amortization 8.05 8.05
11% 11%
3%
EBIT (Operating Income) EBIT -2.07 -2.07
94% 94%
-1%
Net Profit 27 27
527% 527%
10%

In millions USD.

Don't miss a Thing! We will send you all news about Dynavax Technologies Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Dynavax Technologies Corporation Stock News

Neutral
PRNewsWire
7 days ago
EMERYVILLE, Calif. , April 22, 2025 /PRNewswire/ -- Dynavax Technologies Corporation (NASDAQ: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative vaccines, will report first quarter 2025 financial results on Tuesday, May 6, 2025, after the U.S. financial markets close.
Neutral
Business Wire
8 days ago
GREENWICH, Conn.--(BUSINESS WIRE)--Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”), one of the largest shareholders of Dynavax Technologies Corporation (NASDAQ: DVAX) (“Dynavax”, “DVAX” or the “Company”), with ownership of approximately 14.53% of the Company's outstanding shares, today announced that it has filed a definitive proxy statement in connection with its n...
Neutral
PRNewsWire
12 days ago
Urges Stockholders to Vote "FOR" All Four Dynavax Director Nominees on the GOLD Proxy Card Highlights Record Financial and Operational Results, Balanced Capital Allocation Strategy andMeaningful Board Refreshment Underscores Deep Track's Value Destructive, Short-Term Focus and Unnecessary Proxy Contest EMERYVILLE, Calif. , April 17, 2025 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq:...
More Dynavax Technologies Corporation News

Company Profile

Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development and commercialization of novel vaccines and immuno-oncology therapeutics. The firm focuses on leveraging the body's innate and adaptive immune responses through toll-like receptor stimulation. It offers products for vaccines, cancer immunotherapy, and immune-mediated diseases. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Berkeley, CA.

Head office United States
CEO Ryan Spencer
Employees 405
Founded 1996
Website www.dynavax.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today